Shanghai United Imaging Healthcare Co., Ltd. (SHA:688271)
China · Delayed Price · Currency is CNY 131.00
+3.55 (2.79%)
At close: Feb 26, 2026
SHA:688271 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 13,821 | 9,884 | 11,171 | 9,024 | 7,147 |
Other Revenue | - | 416.04 | 239.52 | 214.11 | 106.39 |
| 13,821 | 10,300 | 11,411 | 9,238 | 7,254 | |
Revenue Growth (YoY) | 34.18% | -9.73% | 23.52% | 27.36% | 25.91% |
Cost of Revenue | - | 5,287 | 6,082 | 4,845 | 3,693 |
Gross Profit | 13,821 | 5,013 | 5,328 | 4,394 | 3,561 |
Selling, General & Admin | - | 2,384 | 2,173 | 1,761 | 1,350 |
Research & Development | - | 1,757 | 1,725 | 1,304 | 967.03 |
Other Operating Expenses | 11,802 | -226.81 | -281.35 | -218.46 | -164.54 |
Operating Expenses | 11,802 | 4,054 | 3,675 | 2,941 | 2,173 |
Operating Income | 2,019 | 959.42 | 1,654 | 1,453 | 1,389 |
Interest Expense | - | -2.52 | -0.13 | -6.42 | -3.3 |
Interest & Investment Income | - | 214.35 | 285.02 | 108.13 | 90.39 |
Currency Exchange Gain (Loss) | - | 8.37 | -14.69 | 15.46 | 4.85 |
Other Non Operating Income (Expenses) | -18.91 | -9.99 | -11.94 | -5.91 | -4.35 |
EBT Excluding Unusual Items | 2,000 | 1,170 | 1,912 | 1,564 | 1,476 |
Gain (Loss) on Sale of Investments | - | 37 | -6.06 | 28.5 | -10.59 |
Gain (Loss) on Sale of Assets | - | -0.87 | 0.01 | -0.14 | -0.17 |
Asset Writedown | - | -0.55 | -0.4 | - | -1.71 |
Other Unusual Items | - | 146.5 | 236.57 | 327.25 | 233.77 |
Pretax Income | 2,000 | 1,352 | 2,142 | 1,920 | 1,698 |
Income Tax Expense | 112.09 | 109.78 | 164.5 | 269.71 | 294.03 |
Earnings From Continuing Operations | 1,888 | 1,242 | 1,978 | 1,650 | 1,404 |
Minority Interest in Earnings | - | 19.95 | -3.46 | 6 | 13.68 |
Net Income | 1,888 | 1,262 | 1,974 | 1,656 | 1,417 |
Net Income to Common | 1,888 | 1,262 | 1,974 | 1,656 | 1,417 |
Net Income Growth | 49.60% | -36.09% | 19.21% | 16.86% | 56.96% |
Shares Outstanding (Basic) | 824 | 819 | 823 | 756 | 723 |
Shares Outstanding (Diluted) | 824 | 819 | 823 | 756 | 723 |
Shares Change (YoY) | 0.61% | -0.39% | 8.78% | 4.58% | 3.99% |
EPS (Basic) | 2.29 | 1.54 | 2.40 | 2.19 | 1.96 |
EPS (Diluted) | 2.29 | 1.54 | 2.40 | 2.19 | 1.96 |
EPS Growth | 48.70% | -35.83% | 9.59% | 11.73% | 50.93% |
Free Cash Flow | - | -2,565 | -943.31 | -58.52 | 595.72 |
Free Cash Flow Per Share | - | -3.13 | -1.15 | -0.08 | 0.82 |
Dividend Per Share | - | 0.200 | 0.250 | 0.201 | - |
Dividend Growth | - | -20.00% | 24.38% | - | - |
Gross Margin | 100.00% | 48.67% | 46.70% | 47.56% | 49.09% |
Operating Margin | 14.61% | 9.31% | 14.49% | 15.73% | 19.14% |
Profit Margin | 13.66% | 12.25% | 17.30% | 17.93% | 19.54% |
Free Cash Flow Margin | - | -24.90% | -8.27% | -0.63% | 8.21% |
EBITDA | 2,393 | 1,334 | 1,968 | 1,716 | 1,625 |
EBITDA Margin | 17.32% | 12.95% | 17.24% | 18.58% | 22.41% |
D&A For EBITDA | 374.51 | 374.51 | 313.79 | 263.3 | 236.53 |
EBIT | 2,019 | 959.42 | 1,654 | 1,453 | 1,389 |
EBIT Margin | 14.61% | 9.31% | 14.49% | 15.73% | 19.14% |
Effective Tax Rate | 5.61% | 8.12% | 7.68% | 14.05% | 17.32% |
Revenue as Reported | - | 10,300 | 11,411 | 9,238 | 7,254 |
Advertising Expenses | - | 53.37 | 29.17 | 13.31 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.